JH Hoofnagle, AM Di Bisceglie - The New England Journal of Medicine, 1997 - nejm.highwire.org Chronic viral hepatitis is the principal cause of chronic liver disease,
cirrhosis, and hepatocellular carcinoma in the world and now ranks as the chief
reason for liver transplantation in adults. 1 , 2 , 3 Of the five known ... Cited by 861 - Related articles - All 4 versions
N Enomoto, I Sakuma, Y Asahina, M Kurosaki … - The New England journal of medicine, 1996 - nejm.highwire.org Results A complete response, as evidenced by the absence of HCV RNA in serum on
nested reverse-transcription PCR for six months after therapy, did not occur in
any of the 30 patients whose NS5A2209–2248 sequences were identical to ... Cited by 618 - Related articles - BL Direct - All 6 versions
C Niederau, S Lange, T Heintges, A Erhardt, … - Hepatology, 1998 - interscience.wiley.com The prognosis of chronic hepatitis C virus (HCV) infection is still ill-defined.
The present study prospectively evaluated mortality and complications in a large
cohort of patients with chronic hepatitis C. The study included 838 ... Cited by 379 - Related articles - BL Direct - All 3 versions
TE Wiley, M McCarthy, L Breidi, M McCarthy, … - Hepatology, 1998 - interscience.wiley.com In patients infected with the hepatitis C virus (HCV), 20% to 30% will progress
to cirrhosis in over two to three decades. Viral and host factors that are
important in the clinical and histologic progression of HCV infection are ... Cited by 306 - Related articles - BL Direct - All 3 versions
SA Villano, D Vlahov, KE Nelson, S Cohn, … - Hepatology, 1999 - journals.pasteur.ac.ir The purpose of this investigation was to prospectively characterize acute
hepatitis C virus (HCV) infections and to evaluate the hypothesis that the
outcome is affected by identifiable clinical or viral factors. One hundred ... Cited by 296 - Related articles - BL Direct - All 5 versions
L Serfaty, H Aumaitre, O Chazouillères, AM … - Hepatology, 1998 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 291 - Related articles - BL Direct - All 3 versions
A Kasahara, N Hayashi, K Mochizuki, M … - Hepatology, 1998 - interscience.wiley.com To elucidate the risk factors for liver carcinogenesis and to examine the
incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022
chronic hepatitis C patients treated with interferon were followed by ... Cited by 274 - Related articles - BL Direct - All 3 versions
C Féray, L Caccamo, GJM Alexander, B Ducot, … - Gastroenterology, 1999 - Elsevier In 1994 a questionnaire was sent to 56 liver transplant centers, all members of
the European Liver Transplantation Registry, asking for data on all
anti-HCV–positive patients (by second-generation test) who had undergone ... Cited by 267 - Related articles - All 5 versions
- ►nih.gov NN Zein - Clinical microbiology reviews, 2000 - cmr.highwire.org On the basis of phylogenetic analysis of nucleotide sequences, multiple
genotypes and subtypes of hepatitis C virus (HCV) have been identified.
Characterization of these genetic groups is likely to facilitate and ... Cited by 261 - Related articles - BL Direct - All 9 versions
K Rajender Reddy, TL Wright, PJ Pockros, M … - Hepatology(Baltimore, Md.), 2001 - cat.inist.fr Administration of interferon(IFN) 3 times weekly in patients with chronic
hepatitis C(CHC) is associated with low sustained responses, which may be, in
part, related to this regimen's inability to maintain IFN concentrations ... Cited by 246 - Related articles - BL Direct - All 3 versions
